RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016
ANN ARBOR, Mich.--(BUSINESS WIRE)--RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, today announced that the MIT Technology Review has selected RetroSense as one of the 50 Smartest Companies in 2016.
